MarkOrmanHardinMD

PubMed

• 17 citations
  Initial phase I/IIa trial results of an autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in patients with solid tumors.
  Garth S. Herbert, Timothy J. Vreeland, Guy T. Clifton, Julia M. Greene, Doreen O. Jackson, Mark O. Hardin, Diane F. Hale, John S. Berry, Pauline Nichol, Sook Yin, Xian...> ;Vaccine. 2018 May 31
• 9 citations
  Tumor lysate particle loaded dendritic cell vaccine: preclinical testing of a novel personalized cancer vaccine.
  Mark O. Hardin, Timothy J. Vreeland, Guy T. Clifton, Diane F. Hale, Garth S. Herbert, Julia M. Greene, Doreen O. Jackson, John E Berry, Pauline Nichols, Sook Yin, Xian...> ;Immunotherapy. 2018 Apr 1
• 7 citations
  Standard vs Expanded Indications for Esophageal Magnetic Sphincter Augmentation for Reflux Disease.
  John Kuckelman, Cody J. Phillips, Mark O. Hardin, Matthew J. Martin> ;JAMA Surgery. 2017 Sep 1
• 8 citations
  Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients
  Doreen O. Jackson, Kevin Byrd, Timothy J. Vreeland, Diane F. Hale, Garth S. Herbert, Julia M. Greene, Erika J Schneble, John S. Berry, Alfred F. Trappey, Guy T. Clifto...> ;Oncotarget. 2017 Feb 28
• 3 citations
  The true impact of breast magnetic resonance imaging on the management of in situ disease: more is not better.
  Michael S. Lallemand, Morgan R. Barron, Jason Bingham, Andrew Mosier, Mark O. Hardin, Vance Y. Sohn> ;American Journal of Surgery. 2017 Jan 1
• 5 citations
  Evaluation of attenuated tumor antigens and the implications for peptide-based cancer vaccine development
  John S. Berry, Timothy J. Vreeland, D F Hale, Doreen O. Jackson, Alfred F. Trappey, Julia M. Greene, Mark O. Hardin, Garth S. Herbert, Guy T. Clifton, George E. Peoples> ;Journal of Cancer. 2017 May 11
• 26 citations
  A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor–dendritic cell fusion (dendritoma) vaccine with low dose interleukin-2
  Julia M. Greene, Erika J Schneble, Doreen O. Jackson, Diane F. Hale, Timothy J. Vreeland, Madeline Flores, Jonathan Martin, Garth S. Herbert, Mark O. Hardin, Xianzhong...> ;Cancer Immunology, Immunotherapy. 2016 Feb 19
• 17 citations
  Mucormycosis attributed mortality: A seven-year review of surgical and medical management
  Thomas A. Mitchell, Mark O. Hardin, Clinton K. Murray, John D. Ritchie, Leopoldo C. Cancio, Evan M. Renz, Christopher E. White> ;Burns. 2014 Dec 1
• 7 citations
  Plasma-to-Red Cell Ratio and Mechanism of Injury in Massively Transfused Combat Casualties
  Mark O. Hardin, John D. Ritchie, James K. Aden, Lorne H. Blackbourne, Christopher E. White> ;Military Medicine. 2014 Jan 3
• 6 citations
  Outcomes after cardiac arrest in an adult burn center.
  Jonathan C. Wilton, Mark O. Hardin, John D. Ritchie, Kevin K. Chung, James K. Aden, Leopoldo C. Cancio, Steven E. Wolf, Christopher E. White> ;Burns. 2013 Dec 1
• 20 citations
  Compartment syndrome performance improvement project is associated with increased combat casualty survival.
  John F. Kragh, James San Antonio, John W. Simmons, James E. Mace, Daniel J. Stinner, Christopher E. White, Raymond Fang, James K. Aden, Joseph R. Hsu, Brian J. Eastrid...> ;The Journal of Trauma and Acute Care Surgery. 2013 Jan 1
• 10 citations
  An experience in the management of the open abdomen in severely injured burn patients.
  Mark O. Hardin, James E. Mace, John D. Ritchie, Kevin K. Chung, Katharine W. Markell, Evan M. Renz, Steven E. Wolf, Lorne H. Blackbourne, Christopher E. White> ;Journal of Burn Care & Research. 2012 Jul 1
• 353 citations
  Died of wounds on the battlefield: causation and implications for improving combat casualty care.
  Brian J. Eastridge, Mark O. Hardin, Joyce Cantrell, Lynne Oetjen-Gerdes, Tamara Zubko, Craig T. Mallak, Charles E. Wade, John W. Simmons, James E. Mace, Robert L. Mabr...> ;The Journal of Trauma. 2011 Jul 1
• 15 citations
  Mechanism of injury affects acute coagulopathy of trauma in combat casualties.
  John W. Simmons, Christopher E. White, John D. Ritchie, Mark O. Hardin, Michael A. Dubick, Lorne H. Blackbourne> ;The Journal of Trauma. 2011 Jul 1
• Use of lanreotide for the treatment of gastrointestinal fistulae.
  Kevin S. Clive, Mark O. Hardin, Christopher E. White, Claire R. Larson, John S. Oh, Stephen M. Cohn> ;Annals of Surgery. 2011 Jan 1
• 34 citations
  Fenoldopam use in a burn intensive care unit: a retrospective study
  John W. Simmons, Kevin K. Chung, Evan M. Renz, Christopher E. White, Casey L. Cotant, Molly A Tilley, Mark O. Hardin, John A. Jones, Lorne H. Blackbourne, Steven E. Wolf> ;BMC Anesthesiology. 2010 Jun 24
• 2 citations
  Effect of Stitch Length on Complications
  Mark O. Hardin, John S. Oh, Christopher E. White, Stephen M. Cohn> ;Archives of Surgery. 2010 Jun 1
• Join now to see all